VAERS reports by lot

GSK Varicella/Shingles lot 4H9G2: VAERS reports

63 VAERS reports list lot 4H9G2 as a GSK Varicella/Shingles vaccine, received between 2019-06-29 and 2023-10-06. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
63
Reports
0%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction5727%
General / Systemic (non-local)4923%
Neurological2311%
Dermatological (non-injection-site)2311%
Musculoskeletal178%
Allergic / Anaphylactic147%
Gastrointestinal115%
Cardiac / Cardiovascular94%
Psychiatric / Neuropsychiatric52%
Respiratory10%

Where reports came from

U.S. state of the reporter, where given (top 12).

California9
New York8
Missouri7
Oregon5
New Hampshire3
Minnesota3
Wisconsin3
Ohio2
Massachusetts2
Pennsylvania2
Nebraska2
Virginia2

Reports by month received

2019-062
2019-0730
2019-088
2019-096
2019-108
2019-121
2020-022
2020-031
2020-082
2020-111
2021-021
2023-101

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.